Breaking News

Research grants as political ammo; Death to dyes?

April 22, 2025
john-wilkerson-avatar-teal
Washington Correspondent, D.C. Diagnosis Writer

STAT won its first National Magazine Award for General Excellence. Not bad, huh? Help us keep up the good work by sending me tips at John.Wilkerson@statnews.com or via Signal at John_Wilkerson.07.

research funding

Using research grants as ammo against DEI programs, Israel boycotts

Anil Oza scooped that the Trump administration will use research funding to attack universities it deems discriminatory or antisemitic.

The NIH will withhold grants from universities that have DEI programs or that boycott Israeli companies or companies doing business in Israel, according to the new terms and conditions for research grants. Anil reported on a draft of the terms and conditions hours before they were published. 

Read more from Anil about how attacks on efforts to diversify science are spilling over into private institutions. 


food regulation

Death to dyes (at least petroleum-based ones)

HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary are scheduled to announce plans today for phasing out petroleum-based synthetic dyes from food.

Kennedy is touting the announcement as a major step in the Make America Healthy Again movement.

Days before President Biden left office, the FDA banned red dye No. 3 from food and ingested drugs.

Most food dyes are made from synthetic petroleum-based chemicals, according to the nonprofit Center for Science in the Public Interest. Food dyes are primarily used in food that isn't good for you, including candy, soda pop, and gelatin desserts.

Some food additives and flavorings that are labeled as natural are synthetically derived from non-petroleum sources.



 

drug pricing

Can six drugs be one?

When Medicare came up with the first 10 drugs for price negotiation, it counted six of Novo Nordisk's products as a single drug because they all contain the same active ingredient: insulin aspart. 

A federal appeals court is considering a case over whether judges are allowed to second guess Medicare when it lumps together multiple drugs. 

This case hasn't gotten much attention compared to the constitutional challenges to Medicare drug price negotiation. That's understandable. But the outcome of the lawsuit could have a big impact on the government's ability to control Medicare drug spending. That's especially true in the short term if Medicare decides to cover weight-loss drugs, which for now it has declined to do. But that could change. 

Read my rundown of the oral arguments, judges' questions, and what can be gleaned from them.


drug tariffs

The luck of the Irish may run out

STAT's European correspondent Andrew Joseph traveled to Dublin and County Cork, Ireland, to hear about what pharmaceutical tariffs would mean for both the Irish and Americans

President Trump said he plans to levy tariffs on pharmaceuticals, and he has singled out Ireland, which is a major hub for big pharmaceutical companies. The U.S. trade imbalance with Ireland is largely driven by pharmaceutical exports, which Trump sees as a particular injustice. As a result, the industry is now caught in his crosshairs, anxiously awaiting details from the administration.

The tariffs are meant to return drug manufacturing to the United States, but experts say that's unlikely, at least anytime soon. Instead, they predict increased costs on medicines in the U.S. and the possibility of drug shortages.


autism research

RFK Jr.'s shifting timeline to figure out autism

After promising to find the cause of autism by September, Kennedy clarified the timing. 

"I think we'll have some preliminary answers in six months, but we — it'll take us probably a year from then before we can have definitive answers because a lot of these studies will not go out until the end of the summer," Kennedy told Fox News host Sean Hannity on Friday. 

Kennedy said HHS will "farm the studies out to 15 premier research groups." Those groups will study food additives, pesticides, drugs and, yes, vaccines.

When STAT's Isabella Cueto called nearly two dozen prominent voices from mainstream autism research and the anti-vaccine world, she couldn't find any who had yet been contacted about doing the studies. 


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • White House trumpets Covid lab leak theory on web page that was devoted to health information, STAT
  • U.S. Supreme Court appears likely to uphold ACA preventive care coverage mandate, AP
  • Medical journal receives U.S. attorney letter seeking information about alleged bias, STAT
  • Harvard sues Trump administration over funding freeze, Boston Globe
  • Hospital chains' Medicaid profits are a juicy target for GOP budget hawks, WSJ


Thanks for reading! More next week,


Enjoying D.C. Diagnosis? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments